This content was current as of the date it was released. In science and medicine, information is constantly changing and may become out-of-date as new data emerge.
I just recently commenced treatment with Acalabrutinib. With the threat of COVID-19, I am reluctant to meet my doctor for monitoring at the Cancer Centre where he is located. IS IT UNREASONABLE FOR ME TO REQUEST THAT MY BLOODWORK BE DONE AT A LOCAL LAB AND THAT MY APPOINTMENTS WITH HIM ARE BY PHONE/VIDEO?
Do ask. Blood draws at a local lab and a virtual visit is a reasonable request and is being done on a case by case basis at many centers.
In regard to clinical trials, many research centers are now allowing patients assessed as stable by the trial team to have routine assessments done by local health care providers or when possible, by phone or telemedicine. They are mailing trial medications to patients. In addition, several medical centers are also postponing all non-urgent visits for cancer patients. In fact, they are often insisting that immune suppressed patients stay away and instead are helping them with phone calls or in some cases telemedicine.